Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01559194 · ClinicalTrials.gov registry record · Phase 3

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

A Phase 3 study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
Phase 3
Development phase
82
Enrollment target

NCT01559194 is a Phase 3 study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01559194, a Phase 3 study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
82 participants
Enrollment target

Study Summary

The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.

Interventions

  • BEHAVIORAL Low Fat Diet plus exercise
  • BEHAVIORAL Low Carbohydrate diet + Exercise

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2005-05
Est. Completion 2007-12
Phase Phase 3

What the Registry Record Tells You About NCT01559194

The ClinicalTrials.gov registry entry for NCT01559194 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Low Fat Diet plus exercise is the first listed.

NCT01559194 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01559194 about?

NCT01559194 is a clinical study titled "Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk". The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.

What is the current status of trial NCT01559194?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 82 participants. The study started on 2005-05. Estimated completion is 2007-12.

What interventions are being tested in trial NCT01559194?

The interventions under investigation include: Low Fat Diet plus exercise (BEHAVIORAL), Low Carbohydrate diet + Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01559194?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.